Publication Name	World Journal of Psychiatry
Manuscript ID	105409
Country	Serbia

Category	Psychiatry
Manuscript Type	Minireviews
Article Title	Targeting muscarinic receptors in schizophrenia treatment: Novel antipsychotic xanomeline/trospium chloride
Manuscript Source	Invited Manuscript
All Author List	Ana V Pejčić
Funding Agency and Grant Number
Corresponding Author	Ana V Pejčić, Assistant Professor, PhD, Department of Pharmacology and Toxicology, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovića 69, Kragujevac 34000, Serbia. anapejcic201502@yahoo.com
Key Words	Muscarinic receptors; Schizophrenia; Antipsychotic; Xanomeline; Trospium chloride; Review
Core Tip	Xanomeline/trospium chloride is a potential new treatment option for a wide range of schizophrenia symptoms, offering a relatively favorable tolerability and safety profile. However, additional research is required to better understand its effectiveness and safety in real-world clinical practice, and to define its optimal role in managing this complex psychiatric disorder. As new evidence emerges, it is vital to evaluate it critically.
Citation	Pejčić AV. Targeting muscarinic receptors in schizophrenia treatment: A review of novel antipsychotic xanomeline/trospium chloride. World J Psychiatry 2025; In press

Received	2025-01-21 02:47
Peer-Review Started	2025-01-21 02:47
To Make the First Decision
Return for Revision	2025-03-24 10:15
Revised	2025-04-04 18:55
Second Decision	2025-05-06 06:58
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-05-13 07:39
Articles in Press	2025-05-13 07:39
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript

ISSN	2220-3206 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com